Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Nature Medicine|May 23, 2018
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapyLu Wang, Zibo Zhao, Patrick A Ozark, et al.
Molecular Cell|August 8, 2025
Integrator promotes the association of TFIID and RNA polymerase II to maintain pluripotency during developmentRaghu Ram Edupuganti, Felipe Beckedorff, Pradeep Kumar Reddy Cingaram, et al.
Clinical Trials (London, England)|December 25, 2009
Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung studyVivien M Hsu, Dinesh Khanna, Edwin Smith, et al.
Oncogene|January 26, 2018
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancerDamiano Fantini, Alexander P Glaser, Kalen J Rimar, et al.
Cancer Research|April 5, 2017
Precancer Atlas to Drive Precision Prevention TrialsAvrum Spira, Matthew B Yurgelun, Ludmil Alexandrov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine GliomaHiroaki Katagi, Nundia Louis, Dusten Unruh, et al.
Arthritis and Rheumatism|August 20, 2010
Associations of cigarette smoking with rheumatoid arthritis in African AmericansTed R Mikuls, Harlan Sayles, Fang Yu, et al.
Arthritis and Rheumatism|October 13, 2011
Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African AmericansTed R Mikuls, Tricia Levan, Karen A Gould, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B CellsNida Meednu, Jennifer Barnard, Kelly Callahan, et al.
Nature Medicine|September 15, 2015
The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma developmentAna Ortega-Molina, Isaac W Boss, Andres Canela, et al.
Pageof 27